Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.41 |
| ▸ | FAAH | O00519 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL14485551 | 0.98 | GABRA1 (0.43) | GABRA1GABRB2GABRG2GABRB3TSHR | |
| SCHEMBL10885923 | 0.87 | CYP3A4 (0.43) | GABRA1GABRB2GABRG2GABRB3TSHR | |
| SCHEMBL1561666 | 0.84 | TSHR (0.36) | GABRA1GABRB2GABRG2GABRB3TSHR | |
| SCHEMBL4429459 | 0.83 | GABRA1 (0.39) | GABRA1GABRB2GABRG2GABRB3TSHR | |
| SCHEMBL11846167 | 0.82 | TSHR (0.35) | GABRA1GABRB2GABRG2GABRB3TSHR | |
| SCHEMBL31158055 | 0.82 | P2RX7 (0.39) | GABRA1GABRB2GABRG2GABRB3TSHR | |
| SCHEMBL9766258 | 0.82 | ADRB2 (0.38) | GABRA1GABRB2GABRG2GABRB3TSHR | |
| SCHEMBL8662922 | 0.82 | TSHR (0.35) | GABRA1GABRB2GABRG2GABRB3TSHR | |
| SCHEMBL11265054 | 0.82 | P2RX7 (0.39) | GABRA1GABRB2GABRG2GABRB3TSHR | |
| SCHEMBL9651591 | 0.80 | GABRA1 (0.42) | GABRA1GABRB2GABRG2GABRB3TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230002387-A1 | 2-AMINO-S6-SUBSTITUTED THIOPURINE COMPOUNDS AS INHIBITORS OF THE ENPP1 PROTEIN | ATEN PORUS LIFESCIENCES PVT. LTD. (IN) | 2023-01-05 | — | — | US | disclosed |
| CN-115403684-A | Multipurpose polyolefin catalyst and application thereof | 东北石油大学 | 2022-11-29 | — | — | CN | disclosed |
| CN-114029091-A | Double-ligand catalytic system for selective ethylene trimerization and preparation method and application thereof | 浙江智英石化技术有限公司 | 2022-02-11 | — | — | CN | disclosed |
| CN-107417890-B | Composition, cured product, prepreg, and laminate | 日铁化学材料株式会社 | 2021-07-20 | — | — | CN | disclosed |
| CN-112004851-A | Quaternary nitrogen compounds useful as latent catalysts in curable compositions | 汉高股份有限及两合公司 | 2020-11-27 | — | — | CN | disclosed |
| EP-2154123-B1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2013-10-23 | — | — | EP | disclosed |
| US-8502399-B2 | Resin composition for encapsulating semiconductor and semiconductor device | SUMITOMO BAKELITE CO., LTD. (JP) | 2013-08-06 | — | — | US | disclosed |
| CN-101679171-B | Method for producing benzaldehyde compound | SUMITOMO CHEMICAL CO | 2012-12-12 | — | — | CN | disclosed |
| US-20120080809-A1 | RESIN COMPOSITION FOR ENCAPSULATING SEMICONDUCTOR AND SEMICONDUCTOR DEVICE | SUMITOMO BAKELITE CO., LTD. (JP) | 2012-04-05 | — | — | US | disclosed |
| EP-1256574-B1 | NITROGEN-CONTAINING COMPOUNDS HAVING KINASE INHIBITORY ACTIVITY AND DRUGS CONTAINING THE SAME | KYOWA HAKKO KIRIN CO LTD (JP) | 2012-01-18 | — | — | EP | disclosed |
| EP-0250090-B1 | STORAGE STABLE LATENTLY CURABLE ACRYLIC FORMULATIONS EMPLOYING POLYMERIC HYDROPEROXIDES | LOCTITE CORPORATION (US) | 1992-01-29 | — | — | EP | disclosed |
| US-5028581-A | Odorless multi-valent metal modified products of salicyclic acid copolymers, production processes thereof, and use thereof as color-developing agents for pressure-sensitive copying paper sheets | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1991-07-02 | — | — | US | disclosed |
| US-5023366-A | Reacted with a benzyl halide, alcohol or ether; for pressure sensitive elements | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1991-06-11 | — | — | US | disclosed |
| EP-0361040-A2 | Odorless multi-valent metal modified products of salicylic acid copolymers, production processes thereof, and use thereof as color-developing agents for pressure-sensitive copying paper sheets | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1990-04-04 | — | — | EP | disclosed |
| EP-0360829-A1 | DEHYDROBROMINATION OF SUBSTITUTED ALPHA-HALOCUMENE. | DOW CHEMICAL CO (US) | 1990-04-04 | — | — | EP | disclosed |
| CN-1040377-A | Polyvalent metal modification odorlessness product manufacture method of salicylic acid copolymers and uses thereof | MITSUI TOATSU CHEMICALS (JP) | 1990-03-14 | — | — | CN | disclosed |
| WO-1988009319-A1 | DEHYDROBROMINATION OF SUBSTITUTED alpha-HALOCUMENE | THE DOW CHEMICAL COMPANY (US) | 1988-12-01 | — | — | WO | disclosed |
| EP-0268878-A2 | Salicylic acid copolymers and their metal salts, production process thereof, color-developing agents comprising metal salts of the copolymers and color-developing sheets employing the agents | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1988-06-01 | — | — | EP | disclosed |
| EP-0250090-A2 | Storage stable latently curable acrylic formulations employing polymeric hydroperoxides | LOCTITE CORPORATION (US) | 1987-12-23 | — | — | EP | disclosed |
| US-4452746-A | TO MODIFY PROPERTIES OF HIGH MOLECULAR WEIGHT COMPOUNDS | NIPPON PAINT CO., LTD. (JP) | 1984-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230002387-A1 | 2-AMINO-S6-SUBSTITUTED THIOPURINE COMPOUNDS AS INHIBITORS OF THE ENPP1 PROTEIN | ENPP1, ENPP3, PNP | GABRA1 4514/4885GABRB2 4577/4885GABRG2 4529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.